HRCT of fibrosing lung disease

Respirology

Volumn 20, Issue 6, 2015, Pages 859-872

  Jacob, Joseph ^a   Hansell, David M ^a,b  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

computed tomography; fibrosis; idiopathic interstitial pneumonia; lung; prognosis

Indexed keywords

ARTICLE; BRONCHIECTASIS; CHRONIC HYPERSENSITIVITY PNEUMONITIS; CLASSICAL USUAL INTERSTITIAL PNEUMONIA; CLINICAL FEATURE; DISEASE EXACERBATION; FIBROSING ALVEOLITIS; FIBROSING LUNG DISEASE; FIBROTIC NON SPECIFIC INTERSTITIAL PNEUMONIA; FIBROTIC SARCOIDOSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DISEASE; LUNG FIBROSIS; MORTALITY; NON CLASSICAL USUAL INTERSTITIAL PNEUMONIA; NON SPECIFIC INTERSTITIAL PNEUMONIA; ORGANIZING PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; SMOKING; TRACTION BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS;

HUMANS; LUNG DISEASES, INTERSTITIAL; PULMONARY FIBROSIS; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84937023538     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12531     Document Type: Article

References (63)

1. Oswald N, Parkinson T,. Honeycomb lungs. Q. J. Med. 1949; 18: 1-20.
2. Katzenstein AL, Mukhopadhyay S, Myers JL,. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum. Pathol. 2008; 39: 1275-1294.
3. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J,. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
4. Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H,. Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 1992; 182: 337-342.
5. Arakawa H, Honma K,. Honeycomb lung: history and current concepts. AJR Am. J. Roentgenol. 2011; 196: 773-782.
6. Sundaram B, Gross BH, Martinez FJ, Oh E, Muller NL, Schipper M, Kazerooni EA,. Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. AJR Am. J. Roentgenol. 2008; 191: 1032-1039.
7. Watadani T, Sakai F, Johkoh T, Noma S, Akira M, Fujimoto K, Bankier AA, Lee KS, Müller NL, Song JW, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2013; 266: 936-944.
8. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433-439.
9. Edey AJ, Devaraj AA, Barker RP, Nicholson AG, Wells AU, Hansell DM,. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality. Eur. Radiol. 2011; 21: 1586-1593.
10. Walsh SL, Sverzellati N, Devaraj A, Keir GJ, Wells AU, Hansell DM,. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 2013; 69: 216-222.
11. Walsh SL, Sverzellati N, Devaraj A, Wells AU, Hansell DM,. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur. Radiol. 2012; 22: 1672-1679.
12. Sheehan RE, Wells AU, Milne DG, Hansell DM,. Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities. J. Comput. Assist. Tomogr. 2000; 24: 259-261.
13. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM,. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165: 1581-1586.
14. Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, Hansell DM, Nicholson AG,. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44: 585-596.
15. Kim DS, Collard HR, King TE Jr,. Classification and natural history of the idiopathic interstitial pneumonias. Proc. Am. Thorac. Soc. 2006; 3: 285-292.
16. Flaherty KR, Andrei AC, King TE Jr, Raghu G, Colby TV, Wells A, Bassily N, Brown K, du Bois R, Flint A, et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054-1060.
17. Flaherty KR, Thwaite EL, Kazerooni EA, Gross BH, Toews GB, Colby TV, Travis WD, Mumford JA, Murray S, Flint A, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143-148.
18. Travis WD, Matsui K, Moss J, Ferrans VJ,. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19-33.
19. Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE Jr, Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. NEJM 2004; 350: 125-133.
20. King TE Jr, Behr J, Brown KK, du Bois RM, Lancaster L, de Andrade JA, Stähler G, Leconte I, Roux S, Raghu G,. BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 177: 75-81.
21. King TE Jr, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, et al. Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. Lancet 2009; 374: 222-228.
22. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. NEJM 2014; 370: 2071-2082.
23. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. NEJM 2014; 370: 2083-2092.
24. Travis WD, King TE,. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
25. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
26. Hunninghake GW, Lynch DA, Galvin JR, Gross BH, Müller N, Schwartz DA, King TE Jr, Lynch JP 3rd, Hegele R, Waldron J, et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003; 124: 1215-1223.
27. Elliot TL, Lynch DA, Newell JD Jr, Cool C, Tuder R, Markopoulou K, Veve R, Brown KK,. High-resolution computed tomography features of nonspecific interstitial pneumonia and usual interstitial pneumonia. J. Comput. Assist. Tomogr. 2005; 29: 339-345.
28. Richeldi L, Costabel U, Selman M, Kim DS, Hansell DM, Nicholson AG, Brown KK, Flaherty KR, Noble PW, Raghu G, et al. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. NEJM 2011; 365: 1079-1087.
29. Fell CD, Martinez FJ, Liu LX, Murray S, Han MK, Kazerooni EA, Gross BH, Myers J, Travis WD, Colby TV, et al. Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2010; 181: 832-837.
30. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, Ryerson CJ, Ryu JH, Selman M, Wells AU, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013; 188: 733-748.
31. Cordier JF,. Organising pneumonia. Thorax 2000; 55: 318-328.
32. Lee JW, Lee KS, Lee HY, Chung MP, Yi CA, Kim TS, Chung MJ,. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am. J. Roentgenol. 2010; 195: 916-922.
33. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K,. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am. J. Roentgenol. 1997; 169: 83-87.
34. Silva CI, Churg A, Muller NL,. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am. J. Roentgenol. 2007; 188: 334-344.
35. Adler BD, Padley SP, Muller NL, Remy-Jardin M, Remy J,. Chronic hypersensitivity pneumonitis: high-resolution CT and radiographic features in 16 patients. Radiology 1992; 185: 91-95.
36. Franquet T, Hansell DM, Senbanjo T, Remy-Jardin M, Muller NL,. Lung cysts in subacute hypersensitivity pneumonitis. J. Comput. Assist. Tomogr. 2003; 27: 475-478.
37. Silva CI, Müller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A,. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288-297.
38. Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW,. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am. J. Roentgenol. 2000; 174: 1751-1757.
39. Criado E, Sánchez M, Ramírez J, Arguis P, de Caralt TM, Perea RJ, Xaubet A,. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30: 1567-1586.
40. Wells AU,. The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)-practical implications. Respir. Res. 2013; 14 (Suppl. 1): S2.
41. Raghu G, Lynch D, Godwin JD, Webb R, Colby TV, Leslie KO, Behr J, Brown KK, Egan JJ, Flaherty KR, et al. Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial. Lancet Respir. Med. 2014; 2: 277-284.
42. Morell F, Villar A, Montero MÁ, Muñoz X, Colby TV, Pipvath S, Cruz MJ, Raghu G,. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir. Med. 2013; 1: 685-694.
43. Ryu JH, Myers JL, Capizzi SA, Douglas WW, Vassallo R, Decker PA,. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest 2005; 127: 178-184.
44. Craig PJ, Wells AU, Doffman S, Rassl D, Colby TV, Hansell DM, Du Bois RM, Nicholson AG,. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275-282.
45. Yousem SA, Colby TV, Gaensler EA,. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin. Proc. 1989; 64: 1373-1380.
46. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y,. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. Care Med. 1994; 150: 670-675.
47. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA,. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997; 155: 242-248.
48. Rosas IO, Ren P, Avila NA, Chow CK, Franks TJ, Travis WD, McCoy JP Jr, May RM, Wu H-P, Nguyen DM, et al. Early interstitial lung disease in familial pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 698-705.
49. King TE Jr, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, Cherniack RM,. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am. J. Respir. Crit. Care Med. 2001; 164: 1025-1032.
50. Antoniou KM, Hansell DM, Rubens MB, Marten K, Desai SR, Siafakas NM, Nicholson AG, du Bois RM, Wells AU,. Idiopathic pulmonary fibrosis: outcome in relation to smoking status. Am. J. Respir. Crit. Care Med. 2008; 177: 190-194.
51. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-593.
52. Mejía M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M,. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
53. Cottin V, Cordier JF,. Combined pulmonary fibrosis and emphysema: an experimental and clinically relevant phenotype. Am. J. Respir. Crit. Care Med. 2005; 172: 1605-1606.
54. Desai SR, Wells AU, Rubens MB, Du Bois RM, Hansell DM,. Traction bronchiectasis in cryptogenic fibrosing alveolitis: associated computed tomographic features and physiological significance. Eur. Radiol. 2003; 13: 1801-1808.
55. Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, Toyokawa K,. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271-279.
56. Ryerson CJ, Urbania TH, Richeldi L, Mooney JJ, Lee JS, Jones KD, Elicker BM, Koth LL, King TE Jr, Wolters PJ, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750-757.
57. Nicholson AG, Addis BJ, Bharucha H, Clelland CA, Corrin B, Gibbs AR, Hasleton PS, Kerr KM, Ibrahim NB, Stewart S, et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500-505.
58. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, Lasky JA, Loyd JE, Noth I, Olman MA, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636-643.
59. Suda T, Kaida Y, Nakamura Y, Enomoto N, Fujisawa T, Imokawa S, Hashizume H, Naito T, Hashimoto D, Takehara, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846-853.
60. Park IN, Kim DS, Shim TS, Lim CM, Lee SD, Koh Y, Kim WS, Kim WD, Jang SJ, Colby TV,. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214-220.
61. Hozumi H, Nakamura Y, Johkoh T, Sumikawa H, Colby TV, Kono M, Hashimoto D, Enomoto N, Fujisawa T, Inui N, et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open 2013; 3: e003132.
62. Parambil JG, Myers JL, Ryu JH,. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 2005; 128: 3310-3315.
63. Kishaba T, Tamaki H, Shimaoka Y, Fukuyama H, Yamashiro S,. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung 2014; 192: 141-149, (English).